Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Tata | ICICI Pru |
| AUM | ₹1,534 Cr | ₹11,188 Cr |
| NAV | ₹38.9215 | ₹160.9400 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | — | 13.9 years |
| Expense ratio | 1.1% | 1.2% |
| Stars | Not rated | ★★★★★ |
| Growth Score | — | 50.70 |
AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.
Returns
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| 1 month | — | +11.83% |
| 3 months | — | +8.21% |
| 6 months | — | +12.55% |
| YTD | — | +2.71% |
| 1 year | — | +1.82% |
| 3 years (CAGR) | — | +13.31% |
| 5 years (CAGR) | — | +11.23% |
| 10 years (CAGR) | — | +13.52% |
| Since launch | — | +14.90% |
Risk
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Volatility | — | 16.3% |
| Downside volatility | — | 10.5% |
| Sharpe | — | 0.42 |
| Sortino | — | 0.65 |
| Calmar | — | 0.78 |
| Return / risk | — | 0.81 |
| Deepest fall | — | −47.76% |
| Days to recover | — | 315 |
| Below its high | — | 0.00% |
Against benchmark
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Alpha | — | −0.39% |
| Beta | — | 0.81 |
| R² | — | 93.9% |
| Up capture | — | 80.4% |
| Down capture | — | 74.5% |
| Tracking error | — | 5.4% |
| Information ratio | — | −0.37 |
| Treynor | — | 0.07 |
Consistency
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Best 1-year | — | +107.57% |
| Middle 1-year | — | +15.44% |
| Worst 1-year | — | −44.09% |
| 1-year periods with a loss | — | 21.7% |
| Middle 3-year | — | +15.68% |
| Positive months | — | 55.6% |
| Best day | — | +4.96% |
| Worst day | — | −5.76% |
| Worst 5% day | — | −1.25% |
| Positive days | — | 55.4% |
| NAVs a year | — | 247 |
SIP of ₹10,000 a month
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| 5-year XIRR | — | +12.42% |
| 5-year value | — | ₹8,24,711 |
| 3-year XIRR | — | +10.26% |
| 1-year XIRR | — | +14.09% |
Holdings overlap i
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Tata India Pharma & Healthcare Fund Direct · filing Oct 2026 | — | 0% |
| ICICI Prudential Banking & Financial Services Fund Direct · filing Oct 2026 | 0% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Tata India Pharma & Healthcare Fund and ICICI Prudential Banking & Financial Services Fund
Overlap
0.0%
smaller weight of each shared stock, added up
Stocks in common
0
of 39 and 49
Weight in common
0% · 0%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
These two funds hold no stock in common in these filings, so their overlap is 0%.
Only in Tata India Pharma & Healthcare Fund (39)
| Sun Pharmaceutical Industries Limited | 7.89% |
| Abbott India Limited | 5.66% |
| Divi's Laboratories Limited | 5.41% |
| Healthcare Global Enterprises Limited | 5.25% |
| Dr. Reddy's Laboratories Limited | 5.14% |
| Torrent Pharmaceuticals Limited | 4.73% |
| Apollo Hospitals Enterprise Limited | 4.55% |
| Max Healthcare Institute Limited | 4.28% |
| Rainbow Childrens Medicare Limited | 4.02% |
| Sai Life Sciences Limited | 3.22% |
| Syngene International Limited | 3.17% |
| Procter & Gamble Health Limited | 3.15% |
| Lupin Limited | 3.13% |
| Cipla Limited | 3.08% |
| Anthem Biosciences Limited | 2.99% |
| Natco Pharma Limited | 2.86% |
| FDC Limited | 2.69% |
| Bayer Cropscience Limited | 2.68% |
| Acutaas Chemicals Limited | 2.40% |
| Pfizer Limited | 2.40% |
| Aster DM Quality Care Limited | 2.33% |
| Biocon Limited | 2.23% |
| Navin Fluorine International Limited | 2.15% |
| Sanofi Consumer Healthcare India Limited | 1.99% |
| Ajanta Pharma Limited | 1.59% |
and 14 smaller holdings (10.8% of the fund).
Only in ICICI Prudential Banking & Financial Services Fund (49)
| ICICI Bank Limited | 14.32% |
| HDFC Bank Limited | 13.29% |
| Kotak Mahindra Bank Limited | 10.38% |
| Axis Bank Limited | 6.82% |
| State Bank of India | 5.07% |
| Cholamandalam Investment and Finance Company Ltd | 3.90% |
| Bajaj Finserv Limited | 3.44% |
| SBI Cards and Payment Services Limited | 3.08% |
| SBI Life Insurance Company Limited | 2.48% |
| HDFC Life Insurance Company Limited | 2.36% |
| ICICI Lombard General Insurance Company Limited | 2.20% |
| Bajaj Finance Limited | 2.08% |
| LIC Housing Finance Limited | 2.06% |
| Anand Rathi Wealth Limited | 1.89% |
| Can Fin Homes Limited | 1.68% |
| Max Financial Services Limited | 1.66% |
| BSE Limited | 1.36% |
| HDB Financial Services Limited | 1.34% |
| Go Digit General Insurance Limited | 1.31% |
| PNB Housing Finance Limited | 1.29% |
| Aavas Financiers Limited | 1.17% |
| Life Insurance Corporation Of India | 1.10% |
| Piramal Finance Limited | 1.08% |
| UTI Asset Management Co Limited | 0.91% |
| SBI Funds Management Limited | 0.90% |
and 24 smaller holdings (10.0% of the fund).
Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.
Sectors and company size
| Tata India Pharma & Healthcare Fund | ICICI Prudential Banking & Financial Services Fund | |
|---|---|---|
| Large companies | 26.8% | 67.1% |
| Mid companies | 30.4% | 12.3% |
| Small companies | 40.2% | 16.9% |
| Top 10 holdings | 50.1% | 65.2% |
| Largest sector | Pharmaceuticals & Biotechnology 64% | Banks 51% |